Proinflammatory cytokine expression in gastric tissue from children with Helicobacter pylori-associated gastritis

E Guiraldes1, I Duarte, A Peña

  • 1Departamentos de Pediatría y Anatomía Patológica, Pontificia Universidad Católica de Chile, Santiago, Chile. eguirald@puc.cl

Insights

Helicobacter pylori infection in children increases gastric mucosal production of interleukin-1 beta (IL-1β) and interleukin-8 (IL-8). These inflammatory cytokines are linked to H. pylori-associated gastric damage and varied clinical outcomes in pediatric patients.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Immunology

Background:

  • Helicobacter pylori (H. pylori) infection is common in childhood, leading to chronic gastric inflammation.
  • Inflammatory cytokines are elevated during chronic inflammation, but data in children are limited.
  • Understanding cytokine involvement in pediatric H. pylori infection is crucial for managing gastric damage.

Purpose of the Study:

  • To investigate the concentrations of key inflammatory cytokines in the gastric mucosa of H. pylori-infected children.
  • To correlate cytokine levels with clinical, histologic, and sociodemographic factors.
  • To elucidate the role of specific cytokines in H. pylori-associated gastric pathology in pediatric populations.

Main Methods:

  • Studied 79 children (ages 5-18) undergoing upper gastrointestinal endoscopy in Chile.
  • Measured concentrations of IL-1β, IL-6, IL-8, and TNF-α in gastric mucosal biopsies.
  • Utilized reverse transcription polymerase chain reaction (RT-PCR) for cytokine expression analysis and correlated data with patient status.

Main Results:

  • H. pylori colonization was inversely related to socioeconomic status and positively to age.
  • Significantly higher IL-1β, IL-8, and TNF-α levels were found in H. pylori-positive children and those with gastritis.
  • Elevated IL-1β and IL-8 were observed in children with peptic ulcer disease; IL-6 levels were comparable across groups.

Conclusions:

  • Increased gastric mucosal production of IL-1β and IL-8 is likely involved in H. pylori-induced gastric damage in children.
  • These cytokines may play a critical role in determining diverse clinical outcomes of H. pylori infection in pediatric patients.
  • The findings highlight the importance of specific inflammatory mediators in pediatric H. pylori pathogenesis.
Abstract

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...